Fact CheckerSign in

NCT06293703Recruiting

Effect of Limb Length Ratio on Roux-en-Y Gastric Bypass Outcomes (CLIMB II Study)

Source: ClinicalTrials.gov · Last updated 20 Mar 2026

Brief summary (registry, in English)

The investigators propose a randomized controlled trial comparing BP and roux limb lengths measuring 30 and 15% respectively of patient's total small bowel length versus current standard practice using fixed lengths. The findings would provide further insight into feasibility of standardizing RYGB limb lengths and optimizing resultant weight loss and metabolic effects. The investigators hypothesize RYGB with ratio-adjusted limb lengths (aRYGB) will result in higher total weight loss and resolution of metabolic syndrome comorbidities, including diabetes, hyperlipidemia, and hypertension compared to standard fixed-length RYGB (sRYGB). The study will also utilize the Short Form Rand 36-Item Health Survey (SF36) to determine differences in postoperative quality of life metrics.

Status (registry)
Recruiting
Study type
Interventional
Enrollment
262 (estimated)
First submitted
19 Feb 2024
Start date
12 Jan 2024
Primary completion date
11 Dec 2030
Lead sponsor
Salvador Navarrete
Diseases
Obesity
NCT number
NCT06293703

What you commit to

  • Study type: Interventional
  • Planned participants: 262
  • From 12 Jan 2024 to the primary completion date, 11 Dec 2030
  • 1 site in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Prior treatment

  • patients with history of previous bariatric surgery procedures
  • previous gastric or small bowel resection

Other illness

  • active cancer

Other

  • individuals unable to understand and sign a written consent form
  • presence of a severe and evolutive life threatening pathology unrelated to obesity
  • pregnancy or desired to be pregnant during the study
  • mentally unbalanced patients under supervision or guardianship, patient unable to give consent

Who the study is looking for

  • morbidly obese patients (defined by BMI between 40 and 60).
  • Patient who understands and accepts the need for a long-term follow-up.
  • Patient who agrees to be included in the study

Age in the registry: 18 years to 70 years · Sex: All · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (1)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
Cleveland Clinic
Coordinator of this site? Confirm its status
ClevelandUnited StatesRecruiting

This page is information, not medical advice. Discuss any trial with your doctor.